These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 16628185)
1. Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy. Hambach L; Nijmeijer BA; Drabbels JJ; Falkenburg JH; Goulmy E Leukemia; 2006 Jul; 20(7):1298-300. PubMed ID: 16628185 [No Abstract] [Full Text] [Related]
2. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Schetelig J; Kiani A; Schmitz M; Ehninger G; Bornhäuser M Cancer Immunol Immunother; 2005 Nov; 54(11):1043-58. PubMed ID: 15887014 [TBL] [Abstract][Full Text] [Related]
3. [PRAME protein expressed in leukemia cells as a target molecule for immunotherapy]. Ikeda H; Matsushita M; Kawakami H Rinsho Ketsueki; 1999 Jun; 40(6):484-6. PubMed ID: 10422284 [No Abstract] [Full Text] [Related]
4. Vaccines in leukemia. Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913 [No Abstract] [Full Text] [Related]
5. Marrow grafting and immunotherapy in identical twins with hematologic malignancies. Fefer A; Buckner CD; Clift RA; Fass L; Glucksberg H; Mickelson EM; Neiman P; Storb R; Thomas ED Trans Assoc Am Physicians; 1973; 86():178-84. PubMed ID: 4596452 [No Abstract] [Full Text] [Related]
6. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma. Davison GM Transfus Apher Sci; 2010 Apr; 42(2):189-92. PubMed ID: 20122870 [TBL] [Abstract][Full Text] [Related]
7. Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia. Falkenburg JH; Willemze R Best Pract Res Clin Haematol; 2004 Sep; 17(3):415-25. PubMed ID: 15498713 [TBL] [Abstract][Full Text] [Related]
8. [Prerequisites and possibilities of immunotherapy in acute leukemias]. Zintl F; Plenert W; Aurich G Z Gesamte Inn Med; 1976 Apr; 31(8):227-32. PubMed ID: 1085536 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells. Troeger A; Meisel R; Moritz T; Dilloo D Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533 [TBL] [Abstract][Full Text] [Related]
10. Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation. Montagna D; Maccario R; Locatelli F Int J Immunogenet; 2008 Aug; 35(4-5):389-93. PubMed ID: 18976444 [TBL] [Abstract][Full Text] [Related]
11. On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies. Dellabona P; Casorati G; de Lalla C; Montagna D; Locatelli F Clin Immunol; 2011 Aug; 140(2):152-9. PubMed ID: 21185785 [TBL] [Abstract][Full Text] [Related]
12. Tumour immunity and immunotherapy. Mullins GM Ir J Med Sci; 1978 Sep; 147(9):291-300. PubMed ID: 359503 [No Abstract] [Full Text] [Related]